David Gerhold of Merck Discusses Custom Oligo Microarrays | GenomeWeb


Senior research fellow, genomic pharmacology, Merck & Co.

Initiated Merck’s DNA microarray effort in 1995.

Co-authored first article applying microarrays for drug metabolism and drug safety. “Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays,” Physiological Genomics 5; 161-170, 2001.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.